1. Home
  2. IMMP vs OPBK Comparison

IMMP vs OPBK Comparison

Compare IMMP & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • OPBK
  • Stock Information
  • Founded
  • IMMP 1987
  • OPBK 2005
  • Country
  • IMMP Australia
  • OPBK United States
  • Employees
  • IMMP N/A
  • OPBK N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • OPBK Major Banks
  • Sector
  • IMMP Health Care
  • OPBK Finance
  • Exchange
  • IMMP Nasdaq
  • OPBK Nasdaq
  • Market Cap
  • IMMP 304.0M
  • OPBK 257.1M
  • IPO Year
  • IMMP N/A
  • OPBK 2018
  • Fundamental
  • Price
  • IMMP $2.17
  • OPBK $16.21
  • Analyst Decision
  • IMMP Buy
  • OPBK Hold
  • Analyst Count
  • IMMP 2
  • OPBK 1
  • Target Price
  • IMMP $8.50
  • OPBK $13.00
  • AVG Volume (30 Days)
  • IMMP 147.6K
  • OPBK 25.5K
  • Earning Date
  • IMMP 12-27-2024
  • OPBK 01-23-2025
  • Dividend Yield
  • IMMP N/A
  • OPBK 2.80%
  • EPS Growth
  • IMMP N/A
  • OPBK N/A
  • EPS
  • IMMP N/A
  • OPBK 1.40
  • Revenue
  • IMMP $2,563,302.00
  • OPBK $78,759,000.00
  • Revenue This Year
  • IMMP N/A
  • OPBK N/A
  • Revenue Next Year
  • IMMP $10.84
  • OPBK $12.64
  • P/E Ratio
  • IMMP N/A
  • OPBK $11.28
  • Revenue Growth
  • IMMP 9.59
  • OPBK N/A
  • 52 Week Low
  • IMMP $1.66
  • OPBK $8.91
  • 52 Week High
  • IMMP $3.34
  • OPBK $18.57
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.07
  • OPBK 52.12
  • Support Level
  • IMMP $2.00
  • OPBK $16.75
  • Resistance Level
  • IMMP $2.39
  • OPBK $17.36
  • Average True Range (ATR)
  • IMMP 0.13
  • OPBK 0.56
  • MACD
  • IMMP 0.01
  • OPBK -0.20
  • Stochastic Oscillator
  • IMMP 54.17
  • OPBK 14.80

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

Share on Social Networks: